Early Response to First-Line Anti-PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial.
Voltin CA, Mettler J, van Heek L, Goergen H, Müller H, Baues C, Keller U, Meissner J, Trautmann-Grill K, Kerkhoff A, Fuchs M, Sasse S, von Tresckow B, Dietlein M, Borchmann P, Engert A, Kobe C, Bröckelmann PJ.
Voltin CA, et al. Among authors: van heek l.
Clin Cancer Res. 2021 Jan 15;27(2):402-407. doi: 10.1158/1078-0432.CCR-20-3303. Epub 2020 Oct 29.
Clin Cancer Res. 2021.
PMID: 33122344
Clinical Trial.